Juan Silvestre G Pascual1, Hugues Duffau2,3. 1. Division of Neurosurgery, Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines. 2. Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 80 Avenue Agustin Fliche, 34295, Montpellier, France. h-duffau@chu-montpellier.fr. 3. Team "Plasticity of Central Nervous System, Stem Cells and Glial Tumors, Institute of Functional Genomics, INSERM U1191, University of Montpellier, Montpellier, France. h-duffau@chu-montpellier.fr.
Abstract
OBJECTIVE: For a long time, return to work (RTW) has been neglected in patients harboring a diffuse low-grade glioma (LGG). However, a majority of LGG patients worked at time of diagnosis. Moreover, these patients now live longer given current treatment paradigms, especially thanks to early maximal surgery. METHODS: We systematically searched available medical databases for studies that reported data on RTW in patients who underwent resection for LGG. RESULTS: A total of 30 studies were selected: 19 considered RTW (especially rate and timing) as an outcome and 11 used scales of health-related quality of life (HRQoL) which included work-related aspects. Series that considered RTW as a main endpoint were composed of 1014 patients, with postoperative RTW rates ranging from 31 to 97.1% (mean 73.1%). Timing to RTW ranged from 15 days to 22 months (mean 6.3 months). Factors related to an increased proportion of RTW were: younger age, better neurologic status, having a white-collar occupation, working pre-operatively, being the sole breadwinner, the use of awake surgery, and greater extent of resection. Female sex, older age, poor neurologic status, pre-operative history of work absences, slow lexical access speed, and postoperative seizures were negatively related to RTW. No studies that used HRQoL scales directly investigated RTW rate or timing. CONCLUSIONS: RTW was scarcely analyzed in LGG patients who underwent resection. However, because they are usually young, with no or only mild functional deficits and have a longer life expectancy, postoperative RTW should be assessed more systematically and accurately as a main outcome. As majority (61.5-100%) of LGG patients were working at time of surgery, the responsibility of neurosurgeons is to bring these patients back to their previous activities according to his/her wishes. RTW might also be included as a critical endpoint for future prospective studies and randomized control trials on LGGs.
OBJECTIVE: For a long time, return to work (RTW) has been neglected in patients harboring a diffuse low-grade glioma (LGG). However, a majority of LGG patients worked at time of diagnosis. Moreover, these patients now live longer given current treatment paradigms, especially thanks to early maximal surgery. METHODS: We systematically searched available medical databases for studies that reported data on RTW in patients who underwent resection for LGG. RESULTS: A total of 30 studies were selected: 19 considered RTW (especially rate and timing) as an outcome and 11 used scales of health-related quality of life (HRQoL) which included work-related aspects. Series that considered RTW as a main endpoint were composed of 1014 patients, with postoperative RTW rates ranging from 31 to 97.1% (mean 73.1%). Timing to RTW ranged from 15 days to 22 months (mean 6.3 months). Factors related to an increased proportion of RTW were: younger age, better neurologic status, having a white-collar occupation, working pre-operatively, being the sole breadwinner, the use of awake surgery, and greater extent of resection. Female sex, older age, poor neurologic status, pre-operative history of work absences, slow lexical access speed, and postoperative seizures were negatively related to RTW. No studies that used HRQoL scales directly investigated RTW rate or timing. CONCLUSIONS: RTW was scarcely analyzed in LGG patients who underwent resection. However, because they are usually young, with no or only mild functional deficits and have a longer life expectancy, postoperative RTW should be assessed more systematically and accurately as a main outcome. As majority (61.5-100%) of LGG patients were working at time of surgery, the responsibility of neurosurgeons is to bring these patients back to their previous activities according to his/her wishes. RTW might also be included as a critical endpoint for future prospective studies and randomized control trials on LGGs.
Authors: Florien W Boele; Linda Douw; Jaap C Reijneveld; Rianne Robben; Martin J B Taphoorn; Neil K Aaronson; Jan J Heimans; Martin Klein Journal: J Clin Oncol Date: 2015-02-09 Impact factor: 44.544
Authors: Neil K Aaronson; Martin J B Taphoorn; Jan J Heimans; Tjeerd J Postma; Chad M Gundy; Guus N Beute; Ben J Slotman; Martin Klein Journal: J Clin Oncol Date: 2011-10-17 Impact factor: 44.544
Authors: Jan C Buckner; Edward G Shaw; Stephanie L Pugh; Arnab Chakravarti; Mark R Gilbert; Geoffrey R Barger; Stephen Coons; Peter Ricci; Dennis Bullard; Paul D Brown; Keith Stelzer; David Brachman; John H Suh; Christopher J Schultz; Jean-Paul Bahary; Barbara J Fisher; Harold Kim; Albert D Murtha; Erica H Bell; Minhee Won; Minesh P Mehta; Walter J Curran Journal: N Engl J Med Date: 2016-04-07 Impact factor: 91.245
Authors: M J van den Bent; D Afra; O de Witte; M Ben Hassel; S Schraub; K Hoang-Xuan; P-O Malmström; L Collette; M Piérart; R Mirimanoff; A B M F Karim Journal: Lancet Date: 2005 Sep 17-23 Impact factor: 79.321
Authors: Heleen F Dorland; Femke I Abma; Corné A M Roelen; Roy E Stewart; Benjamin C Amick; Adelita V Ranchor; Ute Bültmann Journal: Int J Cancer Date: 2017-07-19 Impact factor: 7.396
Authors: I Aguilar-Palacio; P Carrera-Lasfuentes; R Sánchez-Recio; J P Alonso; M J Rabanaque Journal: Public Health Date: 2017-12-01 Impact factor: 2.427
Authors: Linda Dirven; Jammbe Z Musoro; Corneel Coens; Jaap C Reijneveld; Martin J B Taphoorn; Florien W Boele; Mogens Groenvold; Martin J van den Bent; Roger Stupp; Galina Velikova; Kim Cocks; Mirjam A G Sprangers; Madeleine T King; Hans-Henning Flechtner; Andrew Bottomley Journal: Neuro Oncol Date: 2021-08-02 Impact factor: 12.300
Authors: Femke I Abma; Ute Bültmann; Benjamin C Amick Iii; Iris Arends; Heleen F Dorland; Peter A Flach; Jac J L van der Klink; Hardy A van de Ven; Jakob Bue Bjørner Journal: J Occup Rehabil Date: 2018-09